XLRN Acceleron Pharma Inc

Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair.

$126.93  -2.39 (-1.85%)
As of 04/09/2021 15:59:45 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/19/2013
Outstanding shares:  60,549,898
Average volume:  352,580
Market cap:   $7,680,754,561
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00434H108
ISIN:        US00434H1086
Sedol:      BDGTXQ8
Valuation   (See tab for details)
PE ratio:   -46.26
PB ratio:   8.96
PS ratio:   103.80
Return on equity:   -12.71%
Net income %:   -146.84%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy